Human monoclonal IgG anticardiolipin antibodies induce nitric oxide synthase expression

Atherosclerosis

Volumn 185, Issue 2, 2006, Pages 246-253

  Alves, J Delgado ^a   Clapp, B R ^b   Stidwill, R ^b   Chen, P P ^c   Hingorani, A D ^b   Singer, M ^b   Isenberg, D A ^b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Anticardiolipin antibodies; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ARGININE; ARGININE METHYL ESTER; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; DEXTRO ARGININE; IMMUNOGLOBULIN G; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PARAPROTEIN; PHENYLEPHRINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; HEMODYNAMIC PARAMETERS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY BLOOD VESSEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR RING;

ANIMALS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; AORTA; BLOOD PRESSURE; ENZYME INHIBITORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33644504144     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.06.044     Document Type: Article

References (23)

1. R.A. Roubey Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies Blood 84 1994 2854 2867
2. J. Arnout, and J. Vermylen Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants Lupus 7 Suppl. 2 1998 S23 S28
3. R.A. Roubey Mechanisms of autoantibody-mediated thrombosis Lupus 7 Suppl. 2 1998 S114 S119
4. M.A. Khamashta, and G.R.V. Hughes The antiphospholipid antibody syndrome P.J. Maddison D.A. Isenberg P. Woo D.N. Glass Oxford textbook of rheumatology 1998 Oxford Medical Publications Oxford 1202 1216
5. J.E. Joseph, P. Harrison, and I.J. Mackie Platelet activation markers and the primary antiphospholipid syndrome (PAPS) Lupus 7 Suppl. 2 1998 S48 S51
6. P.M. Dobado-Berrios, C. Lopez-Pedrera, and F. Velasco Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome Thromb Haemost 82 1999 1578 1582
7. R.A. Levy, E. Avvad, and J. Oliveira Placental pathology in antiphospholipid syndrome Lupus 7 Suppl. 2 1998 S81 S85
8. P.L. Meroni, E. Raschi, and M. Camera Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome J Autoimmun 15 2000 237 240
9. P.R. Ames, C. Tommasino, and J. Alves Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study Lupus 9 2000 688 695
10. L. Iuliano, D. Pratico, and D. Ferro Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies Blood 90 1997 3931 3935
11. P.R. Ames, J. Nourooz-Zadeh, and C. Tommasino Oxidative stress in primary antiphospholipid syndrome Thromb Haemost 79 1998 447 449
12. A.J. Delgado, P.R. Ames, and S. Donohue Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome Arthritis Rheum 46 2002 2686 2694
13. M. Zhu, T. Olee, and D.T. Le Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies Br J Haematol 105 1999 102 109
14. G. Giovannoni, J.M. Land, and G. Keir Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels Ann Clin Biochem 34 1997 193 198
15. J.E. Freedman, J. Loscalzo, and M.R. Barnard Nitric oxide released from activated platelets inhibits platelet recruitment J Clin Invest 100 1997 350 356
16. J.L. Bouchie, H. Hansen, and E.P. Feener Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system Arterioscler Thromb Vasc Biol 18 1998 1771 1779
17. J.L. Lu, L.M. Schmiege III, and L. Kuo Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide Biochem Biophys Res Commun 225 1996 1 5
18. J.L. Parker, and H.R. Adams Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia Circ Res 72 1993 539 551
19. J. Delgado Alves, N.A. Davies, and L. Mason Anticardiolipin antibody is associated with decreased paraoxonase activity and serum nitric oxide in a mouse model Arthritis Rheum 46 Suppl. 9 2002 S230
20. C. Porta, I. Buggia, and I. Bonomi Nitrite and nitrate plasma levels, as markers of nitric oxide synthesis, in antiphospholipid antibodies-related conditions and in thrombotic thrombocytopenic purpura Thromb Haemost 78 1997 965 967
21. N. Del Papa, L. Guidali, and L. Spatola Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules Clin Exp Rheum 13 1995 179 185
22. P.L. Meroni, E. Raschi, and C. Testoni Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype Arthritis Rheum 44 2001 2870 2878
23. C.L. Cooke, and S.T. Davidge Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells Am J Physiol Cell Physiol 282 2002 C395 C402